ClinicalTrials.gg
Not yet recruitingNCT07538076Updated Apr 20, 2026

Validation of Web-Based Star Cancellation and Line Bisection Tests in Hemiplegic Stroke

An observational study in Stroke, Spatial Neglect and Spatial Neglect After Stroke, sponsored by Istanbul Medeniyet University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Istanbul Medeniyet University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
105
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 487 studies in Stroke with a site in Turkey — 96 open to participants now, 109 under way, 3 of them phase 3. Stroke · Turkey.

Planned enrollment
34th of 164
105 · median 63
Started
2026
with 62 others
Observational
164 of 487
36 open now
Primary completion
2026-10
later than 61 of 108 live
Registered
438th of 487
by date

Among the 487 studies in Stroke with a site in Turkey, this one is the 34th largest by planned enrollment of the 164 observational ones that give a count, is one of 63 that started in 2026, is one of 164 observational ones, reaches primary completion later than 61 of the 108 other live ones, and was the 438th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

96 of the 487 studies in Stroke with a site in Turkey are open now. Recruiting first, the newest first:

91 more — sign in →

All 96 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 487 studies in Stroke with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this observational study is to evaluate the clinical usability and diagnostic performance of newly developed web-based Star Cancellation and Line Bisection tests in assessing visuospatial neglect in hemiplegic stroke patients. It will also compare these digital tests with conventional paper-and-pencil assessments.

The main questions it aims to answer are:

Can the web-based Star Cancellation and Line Bisection tests accurately distinguish between stroke patients with and without visuospatial neglect? Do digital test parameters (such as completion time, search speed, and search patterns) provide additional clinical information beyond conventional test scores? Researchers will compare the results of the web-based tests with standard paper-and-pencil tests to evaluate their diagnostic accuracy and clinical validity.

Participants will:

Complete conventional paper-and-pencil Star Cancellation and Line Bisection tests Perform web-based (digital) versions of the same tests using a tablet and stylus Undergo routine clinical and cognitive assessments as part of standard care Provide demographic and clinical information

Read the detailed description

This study is designed as a cross-sectional, comparative, diagnostic accuracy and methodological validation study to evaluate newly developed web-based (browser-based) Star Cancellation Test (SCT) and Line Bisection Test (LBT) for the assessment of visuospatial neglect in hemiplegic stroke patients.

Visuospatial neglect is a common neuropsychological condition following stroke, particularly after right hemisphere lesions, and is associated with significant functional impairment. In clinical practice, neglect is typically assessed using paper-and-pencil tests such as cancellation tasks and line bisection tests. While these methods are widely used, they rely on manual scoring and provide limited information about the underlying search process and performance dynamics.

The digital tests developed in this study are designed to preserve the core structure and spatial characteristics of conventional assessments while enabling automated scoring and recording of additional performance metrics. These include process-based parameters such as completion time, search speed, search path characteristics, and ineffective or off-target responses. The system operates on a web-based platform without requiring software installation and is accessible through standard consumer devices, aiming to improve standardization, accessibility, and scalability in clinical settings.

Participants will be recruited from patients admitted to a physical medicine and rehabilitation clinic and will be classified into three groups based on independent clinical assessment: (1) stroke patients with visuospatial neglect, (2) stroke patients without visuospatial neglect, and (3) age- and sex-matched healthy controls without neurological disease. The presence of visuospatial neglect will be determined using routine clinical reference standards, including established paper-and-pencil neuropsychological tests and behavioral assessment scales. Digital test results will not be used in diagnostic classification to avoid incorporation bias.

All participants will complete both conventional paper-and-pencil and web-based versions of the Star Cancellation Test and Line Bisection Test under standardized conditions in a quiet clinical environment. To minimize potential order effects such as fatigue or learning, the sequence of test administration will be counterbalanced across participants. Digital assessments will be performed using a tablet device and stylus pen to ensure consistency in motor and spatial interaction.

The primary objective of the study is to evaluate the diagnostic performance of the digital tests in distinguishing between patients with and without visuospatial neglect. Secondary objectives include examining the additional clinical value of process-based digital metrics and assessing the agreement between conventional and digital test outcomes.

Statistical analyses will be conducted to assess diagnostic accuracy using receiver operating characteristic (ROC) curve analysis, including estimation of area under the curve (AUC), sensitivity, and specificity. Multivariate modeling approaches may be applied to explore the contribution of multiple digital parameters to diagnostic classification. Descriptive and correlational analyses will be used to evaluate relationships between digital performance measures and clinical variables.

Data will be collected and stored in a secure and anonymized format. Automated data capture within the digital platform will reduce manual entry errors and improve data completeness. All analyses will be performed using standard statistical software.

This study aims to provide a clinically applicable, accessible, and standardized digital alternative to conventional visuospatial neglect assessment methods, while also contributing novel process-based performance measures to the field.

03

Conditions studied

  • Stroke
  • Spatial Neglect
  • Spatial Neglect After Stroke

Browse trials for

Keywords

  • Visuospatial Neglect
  • Spatial Neglect
  • Stroke Rehabilitation
  • Digital Assessment
  • Web-Based Assessment
  • Star Cancellation Test
  • Line Bisection Test
  • Neuropsychological Testing
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of adult patients with hemiplegic stroke who are admitted to our physical medicine and rehabilitation clinic, as well as age- and sex-matched healthy control individuals without a history of neurological disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 80 years
  • First-ever ischemic or hemorrhagic stroke
  • Hemiplegia secondary to stroke
  • Stroke in the subacute or chronic phase, defined as 1 to 24 months after stroke onset
  • Ability to provide written

Exclusion criteria

Exclusion Criteria:

  • History of neurological or severe psychiatric disease before stroke that could significantly affect cognitive function or attention, such as brain tumor, traumatic brain injury, vasculitis, multiple sclerosis, or schizophrenia
  • Severe visual field defect not attributable to visuospatial neglect, such as isolated homonymous hemianopia
  • Severe upper extremity motor impairment or apraxia preventing interaction with the tablet or stylus pen
  • Inability to understand test instructions, cooperate with the assessment, or complete the evaluation process
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
105 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke patients with visuospatial neglect

    The diagnosis of visuospatial neglect will be established using standard paper-and-pencil neuropsychological assessments routinely applied in clinical practice, including the Star Cancellation Test, Line Cancellation Test, Line Bisection Test, Letter Cancellation Test, figure copying tasks, and clock drawing test, along with the Catherine Bergego Scale. To classify a participant as having visuospatial neglect, pathological findings must be present in at least two of these assessments, with at least one being a performance-based paper-and-pencil test. These assessments are part of routine clinical evaluation in stroke patients.Digital test results will not be used for diagnostic classification.

    Diagnostic Test: Web-Based Star Cancellation Test · Diagnostic Test: Web-Based Line Bisection Test

  • Stroke patients without visuospatial neglect

    Diagnostic Test: Web-Based Star Cancellation Test · Diagnostic Test: Web-Based Line Bisection Test

  • Control Group

    Age- and sex-matched healthy control individuals without a history of neurological disease

    Diagnostic Test: Web-Based Star Cancellation Test · Diagnostic Test: Web-Based Line Bisection Test

Interventions

  • Diagnostic testWeb-Based Star Cancellation Test

    The intervention consists of a web-based Star Cancellation Test developed by the study investigators for the assessment of visuospatial neglect. This test is implemented as a browser-based application that can be accessed on standard devices without requiring software installation and is administered using a tablet and stylus pen to ensure consistent interaction. The digital Star Cancellation Test is based on the conventional paper-and-pencil version and includes both target and distractor stimuli. In addition to standard scoring, it automatically records performance measures such as the number of omitted targets, laterality index, completion time, search speed, and search path characteristics.

    Also known as: Digital Star Cancellation Test, Star Cancellation Test

  • Diagnostic testWeb-Based Line Bisection Test

    The intervention consists of a web-based Line Bisection Test developed by the study investigators for the assessment of visuospatial neglect. This test is implemented as a browser-based application that can be accessed on standard devices without requiring software installation and is administered using a tablet and stylus pen to ensure consistent interaction. The digital Line Bisection Test follows the conventional paradigm in which participants are asked to mark the midpoint of horizontal lines. In the digital version, line positions vary across trials, and deviation from the true midpoint is calculated automatically, along with measures of variability.

    Also known as: Line Bisection Test, Digital Line Bisection Test

06

What researchers measure

Primary outcomes

  1. Laterality Index of the Digital Star Cancellation Test

    The laterality index is calculated as the proportion of targets identified on the left side relative to the total number of identified targets. It is used to assess spatial bias and distinguish between participants with and without visuospatial neglect.

    Time frame: Baseline (single assessment during study visit)

  2. Mean Deviation in the Digital Line Bisection Test

    Mean deviation represents the average distance between the participant's marked midpoint and the true midpoint of horizontal lines. It is used as a quantitative measure of spatial bias.

    Time frame: Baseline (single assessment during study visit)

Secondary outcomes

  1. Omitted Targets in the Digital Star Cancellation Test

    The total number of target stars not identified during the digital Star Cancellation Test. This measure reflects incomplete visual exploration.

    Time frame: Baseline (single assessment during study visit)

  2. Completion Time of the Digital Star Cancellation Test

    The total time required to complete the digital Star Cancellation Test, recorded automatically by the system.

    Time frame: Baseline (single assessment during study visit)

  3. Search Speed in the Digital Star Cancellation Test

    The rate of target identification during the digital Star Cancellation Test, used to characterize visual search efficiency.

    Time frame: Baseline (single assessment during study visit)

  4. Ineffective or Off-Target Responses in the Digital Star Cancellation Test

    The number of ineffective or off-target marking attempts recorded during the digital Star Cancellation Test.

    Time frame: Baseline (single assessment during study visit)

  5. Variability of Performance in the Digital Line Bisection Test

    The standard deviation of deviations from the true midpoint across lines in the digital Line Bisection Test, used to assess response variability.

    Time frame: Baseline (single assessment during study visit)

  6. Time Spent on Each Side of the Screen in the Digital Star Cancellation Test

    The amount of time spent exploring the left and right halves of the screen during the digital Star Cancellation Test, recorded automatically by the system. This measure is used to assess lateralized visual exploration patterns.

    Time frame: Baseline (single assessment during study visit)

  7. Search Path Characteristics in the Digital Star Cancellation Test

    Process-based measures describing the pattern of visual search during the digital Star Cancellation Test.

    Time frame: Baseline (single assessment during study visit)

Other outcomes

  1. Participant-Reported Feasibility of the Digital Tests

    Feasibility and user experience of the web-based Star Cancellation and Line Bisection tests, assessed using a brief investigator-developed questionnaire administered after completion of the digital assessments.

    Time frame: Baseline (single assessment immediately after test completion)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to privacy and confidentiality considerations, and because the data were collected for a single-center academic study.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Oct 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 12, 2026
First posted
Apr 20, 2026
StartEst.
Apr 15, 2026
Primary completionEst.
Oct 15, 2026
CompletionEst.
Dec 1, 2026
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07538076
Responsible party
Melisa Zengin (MD, Istanbul Medeniyet University) — Principal investigator
First posted
Apr 20, 2026
Start date
Apr 15, 2026 (estimated)
Primary completion
Oct 15, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 20, 2026

Study contacts

Melisa Zengin, MD
Contact
melisazngn@gmail.com
+905414005688

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion